Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment
Open accessThe DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
Objective: ADHD, or Attention-Deficit/Hyperactivity Disorder, is a neurodevelopmental disorder that is known for its high degree of heterogeneity. It often coexists with other psychiatric diseases, especially anxiety and depression. This article reviews recent studies to explore the etiology of comorbid anxiety and depressive disorders in adults with ADHD, analyzing the factors contributing to this elevated comorbidity rate from several perspectives. Additionally, we explore potential directions for future research in this field. Recent findings: ADHD exhibits a high comorbidity rate with anxiety and depressive disorders, due to overlapping and interacting symptoms. Individuals with two or more comorbid conditions often experience increased disease burden, prolonged illness duration, and diminished treatment efficacy. The underlying causes of comorbid anxiety and depression in ADHD patients are highly complex and can be understood from multiple dimensions, including genetics, neurobiology, neurocognition, and neuroimaging. This complexity poses significant challenges for clinical diagnosis and treatment. Currently, the management of ADHD patients with concurrent depression or anxiety may involve pharmaceutical interventions combined with non-pharmacological strategies, including psychotherapy (e.g., cognitive-behavioral therapy, CBT) and digital therapeutics. For patients with comorbid illnesses, these intergrated approaches have demonstrated significant improvements in symptom relief and quality of life enhancement. Summary: ADHD is a highly heterogeneous disorder with a significant comorbidity rate. Recent research has elucidated the pathogenetic mechanisms of ADHD comorbid with depression and anxiety disorders from multiple perspectives. To improve patient functioning, enhance their quality of life, and guide more effective treatments, Further studies are needed to investigate the underlying causes of these comorbid conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Epidemiological studies consistently show high psychiatric comorbidity, with 50–80% of adults meeting criteria for at least one additional mental disorder [106,107].”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [106]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mood and anxiety disorders represent the most common comorbidities, affecting ~50% and 20–50% of adults with ADHD, respectively [106].”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [106]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depressive and anxiety symptoms are typically episodic, often fluctuating with life stressors, whereas attentional deficits in ADHD are chronic, pervasive, and present across developmental stages [106,107].”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [106]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“many individuals treated exclusively for depression or anxiety continue to experience disabling attentional symptoms, delaying recovery [106,112]”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [106]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Comorbidity substantially worsens clinical course, functioning, and safety outcomes, including hospitalization, legal problems, and suicide risk [106].”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
Molecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357
Kaiser, R. H., Andrews-Hanna, J. R., Wager, T. D., & Pizzagalli, D. A. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0071 · Cited by 2,281
Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis
Thomas, R., Sanders, S., Doust, J., Beller, E., & Glasziou, P. (2015) · Pediatrics · doi:10.1542/peds.2014-3482 · Cited by 1,976
Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation
Shaw, P., Eckstrand, K., Sharp, W., Blumenthal, J., Lerch, J. P., Greenstein, D., Clasen, L., Evans, A., Giedd, J., & Rapoport, J. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707741104 · Cited by 1,819
Architectonic subdivision of the human orbital and medial prefrontal cortex
Öngür, D., Ferry, A. T., & Price, J. L. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10609 · Cited by 944
Song, P., Zha, M., Yang, Q., Zhang, Y., Li, X., & Rudan, I. (2021) · Journal of Global Health · doi:10.7189/jogh.11.04009 · Cited by 896 · cited 2×
“Prevalence rates for both subtypes exhibited age-dependent declines, while the persistent subtype demonstrated higher prevalence in low-and middle-income countries (LMICs) (6).”
InfluentialLarge-scale brain systems in ADHD: beyond the prefrontal–striatal model
Castellanos, F. X., & Proal, E. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.11.007 · Cited by 831 · cited 1×
“They also demonstrate hyperactivation of the occipital lobe during tasks requiring inhibition, working memory, and attention (56).”
Collaborators, O. B. O. T. W. W. M. H. S., Fayyad, J., Sampson, N. A., Hwang, I., Adamowski, T., Aguilar-Gaxiola, S., Al-Hamzawi, A., Andrade, L. H. S. G., Borges, G., de Girolamo, G., et al. (2017) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-016-0208-3 · Cited by 824 · cited 1×
“Epidemiological evidence suggests that approximately 50 – 70% of childhood-onset cases persist into adulthood, whereas the prevalence in adults is estimated at 2 – 3%, based on population studies (2).”
The neural correlates of attention deficit hyperactivity disorder: an ALE meta‐analysis
Dickstein, S. G., Bannon, K., Xavier Castellanos, F., & Milham, M. P. (2006) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2006.01671.x · Cited by 745
Adult ADHD and comorbid disorders: clinical implications of a dimensional approach
Katzman, M. A., Bilkey, T. S., Chokka, P. R., Fallu, A., & Klassen, L. J. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1463-3 · Cited by 732 · cited 2×
“About 70% of adults with ADHD also suffer from another mental health issue, such as bipolar disorder, anxiety disorder, substance use disorder, or a personality disorder (7).”
Moffitt, T. E., Houts, R., Asherson, P., Belsky, D. W., Corcoran, D. L., Hammerle, M., Harrington, H., Hogan, S., Meier, M. H., Polanczyk, G. V., et al. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14101266 · Cited by 618
Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder.
Sagvolden, T., Aase, H., Zeiner, P., & Berger, D. (1998) · PubMed · Cited by 491
Agnew-Blais, J. C., Polanczyk, G. V., Danese, A., Wertz, J., Moffitt, T. E., & Arseneault, L. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0465 · Cited by 459
Molecular Genetics of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Mick, E. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.004 · Cited by 411 · cited 1×
“Twin studies estimate ADHD heritability at 0.76 (34).”
InfluentialADHD With Comorbid Anxiety: A Review of the Current Literature
Schatz, D. B., & Rostain, A. L. (2006) · Journal of Attention Disorders · doi:10.1177/1087054706286698 · Cited by 407
Wigman, J. T. W., van Nierop, M., Vollebergh, W. A. M., Lieb, R., Beesdo-Baum, K., Wittchen, H.-U., & van Os, J. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr196 · Cited by 392
Caye, A., Rocha, T. B.-M., Anselmi, L., Murray, J., Menezes, A. M. B., Barros, F. C., Gonçalves, H., Wehrmeister, F., Jensen, C. M., Steinhausen, H.-C., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0383 · Cited by 349
Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder
Sagvolden, T., Aase, H., Zeiner, P., & Berger, D. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00170-8 · Cited by 345
Jarrett, M. A., & Ollendick, T. H. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2008.05.004 · Cited by 311 · cited 1×
“For instance, inattention may arise secondary to anxiety (23), and the presence of anxiety symptoms may exacerbate dif fi culties with attention (24).”
Bernardi, S., Faraone, S. V., Cortese, S., Kerridge, B. T., Pallanti, S., Wang, S., & Blanco, C. (2012) · Psychological Medicine · doi:10.1017/s003329171100153x · Cited by 251
Do Stimulants Protect Against Psychiatric Disorders in Youth With ADHD? A 10-Year Follow-up Study
Biederman, J., Monuteaux, M. C., Spencer, T., Wilens, T. E., & Faraone, S. V. (2009) · Pediatrics · doi:10.1542/peds.2008-3347 · Cited by 246 · cited 2×
“Additionally, early intervention for ADHD patients may alter the developmental trajectory of comorbid conditions during the adult lifespan (62).”
ADHD in adults: A study of clinical characteristics, impairment and comorbidity
Torgersen, T., Gjervan, B., & Rasmussen, K. (2006) · Nordic Journal of Psychiatry · doi:10.1080/08039480500520665 · Cited by 211
Adult ADHD and its comorbidities, with a focus on bipolar disorder
Klassen, L. J., Katzman, M. A., & Chokka, P. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.036 · Cited by 205
Temporal discounting in major depressive disorder
Pulcu, E., Trotter, P. D., Thomas, E. J., McFarquhar, M., Juhasz, G., Sahakian, B. J., Deakin, J. F. W., Zahn, R., Anderson, I. M., & Elliott, R. (2014) · Psychological Medicine · doi:10.1017/s0033291713002584 · Cited by 200 · cited 1×
“Future research is needed to directly compare individuals with and without comorbidities to determine whether the mechanisms driving these increases are fundamentally distinct (54).”
Dimensional psychiatry: reward dysfunction and depressive mood across psychiatric disorders
Hägele, C., Schlagenhauf, F., Rapp, M., Sterzer, P., Beck, A., Bermpohl, F., Stoy, M., Ströhle, A., Wittchen, H.-U., Dolan, R. J., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3662-7 · Cited by 191
The relationships between rumination and core executive functions: A meta-analysis: Y ang et al.
Yang, Y., Cao, S., Shields, G. S., Teng, Z., & Liu, Y. (2017) · Depression and Anxiety · doi:10.1002/da.22539 · Cited by 183
Levin, F. R., Evans, S. M., Brooks, D. J., Kalbag, A. S., Garawi, F., & Nunes, E. V. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.06.012 · Cited by 173
Rice, F., Riglin, L., Thapar, A. K., Heron, J., Anney, R., O’Donovan, M. C., & Thapar, A. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3338 · Cited by 167 · cited 11×
“Speci fi cally, the ANKK1-DRD2 genes are linked to comorbid MDD and Generalized anxiety disorder (GAD) in adults with ADHD, whereas the NCAM1 and DRD2 genes independently contribute to the susceptibility to MDD in these patients (38).”
InfluentialComorbidity between ADHD and Anxiety Disorders across the Lifespan
D’Agati, E., Curatolo, P., & Mazzone, L. (2019) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2019.1628277 · Cited by 165
A Meta-Analysis of Decision-Making and Attention in Adults With ADHD
Mowinckel, A. M., Pedersen, M. L., Eilertsen, E., & Biele, G. (2015) · Journal of Attention Disorders · doi:10.1177/1087054714558872 · Cited by 158
Solberg, B. S., Halmøy, A., Engeland, A., Igland, J., Haavik, J., & Klungsøyr, K. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12845 · Cited by 157
Kratochvil, C. J., Newcorn, J. H., Arnold, L. E., Duesenberg, D., Emslie, G. J., Quintana, H., Sarkis, E. H., Wagner, K. D., Gao, H., & Michelson, D. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000169012.81536.38 · Cited by 152
Abikoff, H., McGough, J. J., Vitiello, B., McCracken, J. T., Davies, M., Walkup, J. T., Riddle, M. A., Oatis, M. D., Greenhill, L. L., Skrobala, A. M., et al. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000155320.52322.37 · Cited by 149
ADHD and Anxiety: Clinical Significance and Treatment Implications
Reimherr, F. W., Marchant, B. K., Gift, T. E., & Steans, T. A. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0859-6 · Cited by 136
Bond, D. J., Hadjipavlou, G., Lam, R. W., McIntyre, R. S., Beaulieu, S., Schaffer, A., & Weiss, M. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400104 · Cited by 133
Brain alterations in adult ADHD: Effects of gender, treatment and comorbid depression
Onnink, A. M. H., Zwiers, M. P., Hoogman, M., Mostert, J. C., Kan, C. C., Buitelaar, J., & Franke, B. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.011 · Cited by 131
Du Rietz, E., Coleman, J., Glanville, K., Choi, S. W., O’Reilly, P. F., & Kuntsi, J. (2018) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.11.013 · Cited by 115
Adult ADHD and comorbid depression: A consensus-derived diagnostic algorithm for ADHD
Binder, C., McIntosh, Kutcher, S., Levitt, Rosenbluth, & Fallu (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s4720 · Cited by 110 · cited 1×
“However, initiating therapies sequentially — rather than simultaneously — is advised to clarify source-speci fi c side effects or inef fi cacy (61).”
McIntyre, R. S., Kennedy, S. H., Soczynska, J. K., Nguyen, H. T. T., Bilkey, T. S., Woldeyohannes, H. O., Nathanson, J. A., Joshi, S., Cheng, J. S. H., Benson, K. M., et al. (2010) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.09m00861gry · Cited by 103
Mindfulness vs psychoeducation in adult ADHD: a randomized controlled trial
Hoxhaj, E., Sadohara, C., Borel, P., D’Amelio, R., Sobanski, E., Müller, H., Feige, B., Matthies, S., & Philipsen, A. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0868-4 · Cited by 102
Anxiety disorders in adult ADHD: A frequent comorbidity and a risk factor for externalizing problems
Quenneville, A. F., Kalogeropoulou, E., Nicastro, R., Weibel, S., Chanut, F., & Perroud, N. A. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114423 · Cited by 89
Visual cortex abnormalities in adults with ADHD: A structural MRI study
Ahrendts, J., Rüsch, N., Wilke, M., Philipsen, A., Eickhoff, S. B., Glauche, V., Perlov, E., Ebert, D., Hennig, J., & Tebartz van Elst, L. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.518624 · Cited by 86
Coughlin, C. G., Cohen, S. C., Mulqueen, J. M., Ferracioli-Oda, E., Stuckelman, Z. D., & Bloch, M. H. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0075 · Cited by 86
The female side of pharmacotherapy for ADHD—A systematic literature review
Kok, F. M., Groen, Y., Fuermaier, A. B. M., & Tucha, O. (2020) · PLOS ONE · doi:10.1371/journal.pone.0239257 · Cited by 86 · cited 5×
“These fi ndings position ATX as a preferential option for females with ADHD, particularly those with comorbid mood disorders (92, 93).”
InfluentialCharacteristics of Children With ADHD and Comorbid Anxiety
Jarrett, M. A., Wolff, J. C., Davis, T. E., Cowart, M. J., & Ollendick, T. H. (2016) · Journal of Attention Disorders · doi:10.1177/1087054712452914 · Cited by 84
Katzman, M., & Sternat, T. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s111818 · Cited by 83
Bouffard, R., Hechtman, L., Minde, K., & Iaboni-Kassab, F. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800806 · Cited by 81
Ohlmeier, M. D., Peters, K., Kordon, A., Seifert, J., Wildt, B. T., Wiese, B., Ziegenbein, M., Emrich, H. M., & Schneider, U. (2007) · Alcohol and Alcoholism · doi:10.1093/alcalc/agm069 · Cited by 79
Knouse, L. E., Zvorsky, I., & Safren, S. A. (2013) · Cognitive Therapy and Research · doi:10.1007/s10608-013-9569-5 · Cited by 78 · cited 1×
“Notably, recent studies have shown that cognitive behavioral treatment (CBT) is effective for both ADHD and depression (88).”
The HTR1A and HTR1B receptor genes influence stress-related information processing
Mekli, K., Payton, A., Miyajima, F., Platt, H., Thomas, E., Downey, D., Lloyd-Williams, K., Chase, D. S., Toth, Z. G., Elliott, R., et al. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.06.013 · Cited by 73 · cited 1×
“Furthermore, research by Mekli et al. suggests that the rs6296 C allele may increase the risk of anxiety in adults when exposed to stressful life events (41).”
Manassis (2007) · Behavioral and Brain Functions · doi:10.1186/1744-9081-3-4 · Cited by 72
Generalised anxiety disorder and hospital admissions: findings from a large, population cohort study
Remes, O., Wainwright, N. W. J., Surtees, P. G., Lafortune, L., Khaw, K., & Brayne, C. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-018539 · Cited by 70 · cited 1×
“Among patients with both conditions, the likelihood of hospitalization (27) and the occurrence of psychotic symptoms (28) are also higher.”
Van Ameringen, M., Mancini, C., Simpson, W., & Patterson, B. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00148.x · Cited by 69 · cited 1×
“Epidemiological and clinical investigations have shown a signi fi cant prevalence of comorbid phobias in children, adolescents (18), and adults (19) with ADHD.”
Mao, A. R., & Findling, R. L. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.09.2799 · Cited by 68
Transdiagnostic neuroimaging of reward system phenotypes in ADHD and comorbid disorders
Grimm, O., van Rooij, D., Hoogman, M., Klein, M., Buitelaar, J. K., Franke, B., Reif, A., & Plichta, M. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.025 · Cited by 68
Durell, T. M., Adler, L. A., Williams, D. W., Deldar, A., McGough, J. J., Glaser, P. E., Rubin, R. L., Pigott, T. A., Sarkis, E. H., & Fox, B. K. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31827d8a23 · Cited by 64
Stimulant treatment of adult attention-deficit/hyperactivity disorder
Spencer, T. J., Biederman, J., & Wilens, T. E. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2003.12.002 · Cited by 61
Clemow, D., Bushe, C., Mancini, M., Ossipov, M., & Upadhyaya, H. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s115707 · Cited by 58
Liu, C., Hua, M., Lu, M., & Goh, K. K. (2023) · Psychology and Psychotherapy: Theory, Research and Practice · doi:10.1111/papt.12455 · Cited by 56
Ter-Stepanian, M., Grizenko, N., Zappitelli, M., & Joober, R. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500506 · Cited by 55
Yuce, M., Zoroglu, S. S., Ceylan, M. F., Kandemir, H., & Karabekiroglu, K. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s54283 · Cited by 55
Cognitive mechanisms underlying depressive disorders in ADHD: A systematic review
Mayer, J. S., Bernhard, A., Fann, N., Boxhoorn, S., Hartman, C. A., Reif, A., & Freitag, C. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.12.018 · Cited by 53 · cited 3×
“…shared neurocognitive impairments in ADHD patients and those with comorbid depression are most likely due to executive function de fi cits — particularly in verbal fl uency, selective attention, working memory, and long-term memory — rather than general cognitive de fi cits related to lower IQ (48).”
InfluentialAlexander, S. J., & Harrison, A. G. (2013) · Journal of Attention Disorders · doi:10.1177/1087054711413071 · Cited by 50 · cited 1×
“Research suggests that stress, depression, and anxiety may result from undiagnosed and untreated ADHD (31).”
Women and attention deficit disorders: A great burden overlooked
Waite, R. (2007) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2006.00203.x · Cited by 48
ANXIOUS AND AGGRESSIVE: THE CO-OCCURRENCE OF IED WITH ANXIETY DISORDERS
Keyes, K. M., McLaughlin, K. A., Vo, T., Galbraith, T., & Heimberg, R. G. (2015) · Depression and Anxiety · doi:10.1002/da.22428 · Cited by 47 · cited 1×
“Consequently, individuals with comorbid anxiety disorders often exhibit heightened aggression (26).”
Mattos, P., Louzã, M. R., Palmini, A. L. F., Oliveira, I. R. D., & Rocha, F. L. (2013) · Journal of Attention Disorders · doi:10.1177/1087054711434772 · Cited by 47
Methylphenidate in treatment of adults with Attention-Deficit/Hyperactivity Disorder
Biederman, J., & Spencer, T. J. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s12 · Cited by 47 · cited 1×
“Regarding age, correlation analyses across studies revealed no signi fi cant association between patient age and treatment outcomes (75).”
Anxiety in College Students With ADHD: Relationship to Cognitive Functioning
Prevatt, F., Dehili, V., Taylor, N., & Marshall, D. (2015) · Journal of Attention Disorders · doi:10.1177/1087054712457037 · Cited by 44
Hutchison, S. L., Ghuman, J. K., Ghuman, H. S., Karpov, I., & Schuster, J. M. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316647686 · Cited by 41
Anxiety reduction on atomoxetine and methylphenidate medication in children with ADHD
Šnircová, E., Husarova, V. M., Hrtánek, I., Kulhan, T., Ondrejka, I., & Nosalova, G. (2015) · Pediatrics International · doi:10.1111/ped.12847 · Cited by 39
Lee, L.-T., Tsai, H. C., Chi, M. H., Chang, W. H., Chen, K. C., Lee, I. H., Chen, P. S., Yao, W. J., Chiu, N. T., & Yang, Y. K. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000067 · Cited by 35
Giacobini, M., Ahnemark, E., Medin, E., Freilich, J., Andersson, M., Ma, Y., & Ginsberg, Y. (2023) · Journal of Attention Disorders · doi:10.1177/10870547231177221 · Cited by 35
Chen, Q., Kuja‐Halkola, R., Sjölander, A., Serlachius, E., Cortese, S., Faraone, S. V., Almqvist, C., & Larsson, H. (2017) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12686 · Cited by 34
Bloch, Y., Aviram, S., Segev, A., Nitzan, U., Levkovitz, Y., Braw, Y., & Mimouni-Bloch, A. (2013) · Journal of Attention Disorders · doi:10.1177/1087054712474949 · Cited by 30 · cited 2×
“This effect persisted even in individuals with mild anxiety, implying that the therapeutic mechanism may not involve direct anxiolysis but could instead arise indirectly through improved attention and ADHD symptom remission (69).”
Nord, C. L., Halahakoon, D. C., Lally, N., Limbachya, T., Pilling, S., & Roiser, J. P. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.022 · Cited by 29
Bron, T. I., Bijlenga, D., Kooij, J. J. S., Vogel, S. W. N., Wynchank, D., Beekman, A. T. F., & Penninx, B. W. J. H. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.022 · Cited by 26
Shang, C.-Y., Sheng, C., Yang, L.-K., Chou, T.-L., & Gau, S. S.-F. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-017-9749-0 · Cited by 26
NCAM1‐TTC12‐ANKK1‐DRD2 gene cluster and the clinical and genetic heterogeneity of adults with ADHD
Mota, N. R., Rovaris, D. L., Kappel, D. B., Picon, F. A., Vitola, E. S., Salgado, C. A. I., Karam, R. G., Rohde, L. A., Grevet, E. H., & Bau, C. H. D. (2015) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32317 · Cited by 25
Predicting Response of ADHD Symptoms to Methylphenidate Treatment Based on Comorbid Anxiety
Blouin, B., Maddeaux, C., Firestone, J. S., & van Stralen, J. (2009) · Journal of Attention Disorders · doi:10.1177/1087054708326269 · Cited by 25 · cited 1×
“On the contrary, some research contradict these fi ndings, reporting no signi fi cant impact of anxiety on MPH response (65).”
On the role ofNOS1ex1f‐VNTR in ADHD—allelic, subgroup, and meta‐analysis
Weber, H., Kittel‐Schneider, S., Heupel, J., Weißflog, L., Kent, L., Freudenberg, F., Alttoa, A., Post, A. M., Herterich, S., Haavik, J., et al. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32326 · Cited by 23
Biederman, J., Mick, E., Spencer, T., Surman, C., & Faraone, S. V. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00233.x · Cited by 20
Regional Brain Volumes and ADHD Symptoms in Middle-Aged Adults: The PATH Through Life Study
Das, D., Cherbuin, N., Anstey, K. J., Abhayaratna, W. P., & Easteal, S. (2014) · Journal of Attention Disorders · doi:10.1177/1087054714523316 · Cited by 19 · cited 1×
“Additionally, a study revealed that adults with ADHD exhibit reduced hippocampal volume, which is associated with higher hyperactivity scores (58), while those with comorbid depression show even smaller hippocampal volumes (59).”
Segev, A., Gvirts, H. Z., Strouse, K., Mayseless, N., Gelbard, H., Lewis, Y. D., Barnea, Y., Feffer, K., Shamay‐Tsoory, S., & Bloch, Y. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.05.009 · Cited by 18 · cited 1×
“Segev et al. (2016), in a crossover trial, identi fi ed a state-dependent interaction: MPH demonstrated greater anxiolytic ef fi cacy in patients with higher baseline anxiety levels (74).”
Lee, D. Y., Kim, C., Shin, Y., & Park, R. W. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.38398 · Cited by 17
Gabriel, A. (2010) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-010-0025-z · Cited by 17
Koyuncu, A., Çelebi, F., Ertekin, E., Kök, B. E., & Tükel, R. (2017) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125317714193 · Cited by 17
Evidence of sexual dimorphism of HTR1B gene on major adult ADHD comorbidities
Müller, D., Grevet, E. H., Panzenhagen, A. C., Cupertino, R. B., da Silva, B. S., Kappel, D. B., Mota, N. R., Blaya‐Rocha, P., Teche, S. P., Vitola, E. S., et al. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.09.011 · Cited by 14
Managing ADHD and Comorbidities in Adults
Newcorn, J. H. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.7129br7c.e40 · Cited by 13 · cited 1×
“Research has shown that stimulant treatment is less effective than non-stimulant treatment for adult patients with ADHD and anxiety disorders (76).”
Koyuncu, A., Çelebi, F., Ertekin, E., & Kahn, D. A. (2015) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000070 · Cited by 12
Cheng, Y., Shyu, Y., Lee, S.-Y., Yuan, S., Yang, C., Yang, K., Lee, T., & Wang, L. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s126438 · Cited by 12
Tsirmpas, C., Nikolakopoulou, M., Kaplow, S., Andrikopoulos, D., Fatouros, P., Kontoangelos, K., & Papageorgiou, C. (2023) · JMIR Formative Research · doi:10.2196/48362 · Cited by 11
Internet-delivered self-help for adults with ADHD (MyADHD): usability study
Kenter, R. M. F., Schønning, A., & Inal, Y. (2022) · JMIR Formative Research · doi:10.2196/37137 · Cited by 10
Oliva, F., Carezana, C., Nibbio, G., Bramante, S., Pomeri, A. P., & Maina, G. (2018) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000320 · Cited by 4
Gutiérrez-Casares, J. R., Segú-Vergés, C., Chueca, J. S., Pozo-Rubio, T., Coma, M., Montoto, C., & Quintero, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1118253 · Cited by 3
[Diagnosis and Treatment of Adult ADHD Comorbid with Mood or Anxiety Disorders].
Okada, T. (2015) · PubMed · Cited by 3
Cited by
ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives
Bogdańska-Chomczyk, E., Majewski, M. K., & Kozłowska, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211020 · Cited by 15
“Notably, many individuals treated exclusively for depression or anxiety continue to experience disabling attentional symptoms, delaying recovery [106,112].”
InfluentialThe Cerebellar Neuropsychiatric Rating Scale Version 2: Development and Validation
Selvadurai, L. P., Burt, A. L., Daly, M. P., Sherman, J. C., & Schmahmann, J. D. (2025) · The Cerebellum · doi:10.1007/s12311-025-01930-y · Cited by 5
The spectrum of neurodevelopmental disorders: comorbidities as clues to pathogenesis
McHugh, C. M., John, J. R., Wu, W. T., & Eapen, V. (2026) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000001068 · Cited by 4
Self-citationExplaining heterogeneity: Latent profiles of adult attention-deficit/hyperactivity disorder
McGuigan, L. M., Simons, M. U., Mengwasser, S. T., Marshall, P., & Hoelzle, J. B. (2025) · Applied Neuropsychology Adult · doi:10.1080/23279095.2025.2568595 · Cited by 3
de Melo, I. H., & França, G. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1813029 · Cited by 4
“The persistent frustration, chronic self-criticism, feelings of inadequacy, and emotional exhaustion associated with unrecognized and untreated ADHD can generate a depressive-like affective state that mimics core symptoms of depression (21).”
Metadata
- Authors
- Fu, X., Wu, W., Wu, Y., Liu, X., Liang, W., Wu, R., & Li, Y.
- Affiliations
- Fujian Medical University (CN)
- Corresponding author
- Li, Yun
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2025-06-06
- Volume
- 16
- Pages
- 1597559-1597559
- ISSN
- 1664-0640 (ISSN-L)
- PMC
- PMC12179154
- OpenAlex
- W4411107682
- Cited by
- 54
- References
- 95
- Citations by year
- 2026: 44 · 2025: 10
- FWCI
- 9.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- adult ADHD, comorbidities, anxiety disorders, depressive disorders, etiology, treatment, cognitive behavioral therapy, digital therapeutics, pharmacotherapy, neurobiology, genetic factors, neuroimaging, neurocognitive function, quality of life
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.